Want to join the conversation?
$ENDP 2Q15 PR: Diluted loss per share attributable to Endo International is $1.35 vs. EPS of $0.13 in 2Q14. 2Q15 reported $0.49 diluted GAAP loss per share from continuing operations, & $1.08 adjusted diluted EPS from continuing operations. Approx. 28MM shares were issued in June 2015 as part of financing to fund acquisition of Par Pharmaceutical.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.